These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31469704)

  • 21. Randomized, Open-Label, Phase 1/2a Study to Determine the Maximum Tolerated Dose of Intraventricular Sustained Release Nimodipine for Subarachnoid Hemorrhage (NEWTON [Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage]).
    Hänggi D; Etminan N; Aldrich F; Steiger HJ; Mayer SA; Diringer MN; Hoh BL; Mocco J; Faleck HJ; Macdonald RL;
    Stroke; 2017 Jan; 48(1):145-151. PubMed ID: 27932607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The evolution of invasive cerebral vasospasm treatment in patients with spontaneous subarachnoid hemorrhage and delayed cerebral ischemia-continuous selective intracarotid nimodipine therapy in awake patients without sedation.
    Paľa A; Schneider M; Brand C; Pedro MT; Özpeynirci Y; Schmitz B; Wirtz CR; Kapapa T; König R; Braun M
    Neurosurg Rev; 2019 Jun; 42(2):463-469. PubMed ID: 29804157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcome of Oral and Intra-arterial Nimodipine Administration After Aneurysmal Subarachnoid Haemorrhage - A Single-centre Study.
    Ehrlich G; Kirschning T; Wenz H; Hegewald AA; Neumaier-Probst E; Seiz-Rosenhagen M
    In Vivo; 2019; 33(6):1967-1975. PubMed ID: 31662526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survey of clinical experience with nimodipine in patients with subarachnoid hemorrhage.
    Tettenborn D; Porto L; Ryman T; Strugo V; Taquoi G; Battye R
    Neurosurg Rev; 1987; 10(2):77-84. PubMed ID: 3329302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nimodipine in subarachnoid hemorrhage.
    DiPalma JR
    Am Fam Physician; 1989 Dec; 40(6):143-5. PubMed ID: 2686374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nimodipine in aneurysmal subarachnoid hemorrhage: a randomized study of intravenous or peroral administration.
    Kronvall E; Undrén P; Romner B; Säveland H; Cronqvist M; Nilsson OG
    J Neurosurg; 2009 Jan; 110(1):58-63. PubMed ID: 18847340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In brief: nimodipine oral solution (Nymalize).
    Med Lett Drugs Ther; 2013 Aug; 55(1423):68. PubMed ID: 23959389
    [No Abstract]   [Full Text] [Related]  

  • 28. Magnesium sulfate in combination with nimodipine for the treatment of subarachnoid hemorrhage: a randomized controlled clinical study.
    Zhang C; Zhao S; Zang Y; Zhao W; Song Q; Feng S; Hu L; Gu F
    Neurol Res; 2018 Apr; 40(4):283-291. PubMed ID: 29540123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Best evidence topic reports. Does nimodipine reduce mortality and secondary ischaemic events after subarachnoid haemorrhage?
    Brown G; Carley S
    Emerg Med J; 2004 May; 21(3):333. PubMed ID: 15107373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of nimodipine in patients with aneurysmal subarachnoid haemorrhage.
    Vinge E; Andersson KE; Brandt L; Ljunggren B; Nilsson LG; Rosendal-Helgesen S
    Eur J Clin Pharmacol; 1986; 30(4):421-5. PubMed ID: 3743617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Are the calcium antagonists really useful in cerebral aneurysmal surgery? A retrospective study.
    Golfinos JG; Thompson BG; Zabramski JM; Spetzler RF
    Neurosurgery; 1994 Sep; 35(3):541-2. PubMed ID: 7800152
    [No Abstract]   [Full Text] [Related]  

  • 32. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
    Ehlert A; Schmidt C; Wölfer J; Manthei G; Jacobs AH; Brüning R; Heindel W; Ringelstein EB; Stummer W; Pluta RM; Hesselmann V
    J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nimodipine-induced acute hypoxemia: case report.
    Devlin JW; Coplin WM; Murry KR; Rengachary SS; Wilson RF
    Neurosurgery; 2000 Nov; 47(5):1243-6; discussion 1246-7. PubMed ID: 11063120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypotensive effect of nimodipine during treatment for aneurysmal subarachnoid haemorrhage.
    Porchet F; Chioléro R; de Tribolet N
    Acta Neurochir (Wien); 1995; 137(1-2):62-9. PubMed ID: 8748871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resistant vasospasm in subarachnoid hemorrhage treated with continuous intraarterial nimodipine infusion.
    Doukas A; Petridis AK; Barth H; Jansen O; Maslehaty H; Mehdorn HM
    Acta Neurochir Suppl; 2011; 112():93-6. PubMed ID: 21691994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Magnesium sulphate for aneurysmal subarachnoid hemorrhage: why, how, and current controversy.
    Wong GK; Poon WS
    Acta Neurochir Suppl; 2013; 115():45-8. PubMed ID: 22890642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of fasudil in patients with subarachnoid hemorrhage: final results of a randomized trial of fasudil versus nimodipine.
    Zhao J; Zhou D; Guo J; Ren Z; Zhou L; Wang S; Zhang Y; Xu B; Zhao K; Wang R; Mao Y; Xu B; Zhang X;
    Neurol Med Chir (Tokyo); 2011; 51(10):679-83. PubMed ID: 22027241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebral vasospasm and calcium channel blockade. Nimodipine treatment in patients with aneurysmal subarachnoid hemorrhage.
    Brandt L; Ljunggren B; Säveland H; Andersson KE; Vinge E
    Acta Pharmacol Toxicol (Copenh); 1986; 58 Suppl 2():151-5. PubMed ID: 3521193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of nimodipine on cerebral blood flow and cerebrovascular reactivity after subarachnoid haemorrhage.
    Rasmussen G; Bergholdt B; Dalh B; Sunde N; Cold G; Voldby B
    Acta Neurol Scand; 1999 Mar; 99(3):182-6. PubMed ID: 10100962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment following aneurysmal subarachnoid hemorrhage].
    Nemec K; Greif R
    Pharm Unserer Zeit; 2005; 34(5):412-6. PubMed ID: 16180364
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.